RVTY241220P105000
- 1.60
- 0.000.00%
Revvity Newsroom
TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $144
Revvity (RVTY) Gets a Buy From TD Cowen
Nephron Downgrades Revvity(RVTY.US) to Sell Rating, Cuts Target Price to $105
Revvity's Resilience and Growth Potential: A Buy Rating Amidst Challenges
Raymond James Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $146
Raymond James Adjusts Price Target on Revvity to $146 From $144, Maintains Outperform Rating
TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $144
Bernstein Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $145
A Quick Look at Today's Ratings for Revvity(RVTY.US), With a Forecast Between $132 to $145
Revvity Is Maintained at Outperform by Baird
Revvity Analyst Ratings
Barclays Reaffirms Their Buy Rating on Revvity (RVTY)
Evercore ISI Adjusts Price Target on Revvity to $134 From $132
Revvity Is Maintained at Outperform by Leerink Partners
Leerink Partners Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $135
Bernstein Adjusts Revvity Price Target to $150 From $145, Maintains Outperform Rating
Barclays Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $140
Revvity Price Target Raised to $140.00/Share From $125.00 by Barclays
Revvity Analyst Ratings
Barclays Upgrades Revvity(RVTY.US) to Buy Rating, Raises Target Price to $140